|
|
Article: Schering Laboratories Awarded Top Honors for CLARINEX(R) (Desloratadine) Direct-to-Consumer Education Program.
- Article from:
- PR Newswire
- Article date:
- November 18, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company Reaffirms Commitment to Consumer Education Through a Variety of Mediums
Schering Laboratories today announced the company has earned several top honors in DTC Perspectives Magazine's annual Perspectives on Excellence Awards. CLARINEX(R) (desloratadine), the only nonsedating antihistamine approved for the treatment of indoor and outdoor allergies, as well as chronic idiopathic urticaria (CIU), or hives of unknown cause, earned Gold in the "DTC Brand of the Year" category. Schering Laboratories won Silver in the "DTC Pharmaceutical Company of the Year" category. These awards honor distinction in the direct-to-consumer (DTC) area, and come as Schering ...